ArthroCare cleared by SEC
This article was originally published in The Gray Sheet
Executive Summary
The Securities & Exchange Commission says in a May 29 letter that it does not intend to recommend enforcement action against ArthroCare following a probe into the firm's stock-option practices. SEC asked to review ArthroCare's financial information in August as part of a widespread investigation into potential options abuses at scores of companies (1"The Gray Sheet" Aug. 28, 2006, In Brief)...